Study guide
10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales
Utah MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC
1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline
2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel
2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel
3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment
3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement
4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing
4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records
5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards
6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration
6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting
7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs
7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program
8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah
8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security
9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database
9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)
10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products
10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales
11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery
11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients
12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs
12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards
13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation
13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits
10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales
Key Takeaways Explain This Topic AI
A Utah retailer may not sell more than 3.6 grams of ephedrine, pseudoephedrine, or phenylpropanolamine to one person in a 24-hour period (Utah Code § 58-37c-208(2)).
Utah pseudoephedrine sellers must keep products where customers cannot reach them, check government photo ID with date of birth, and keep a signed purchase log for at least two years.
In Utah, iodine above 1.5% by weight may be sold only on a prescription from a Utah-licensed veterinarian or physician, or to a person engaged in livestock animal husbandry (Utah Code § 58-37c-204).
A Utah pharmacy technician may counsel on OTC drugs and dietary supplements, but only under the supervising pharmacist's direction (R156-17b-601(1)(j)).
Federal law allows a pharmacist to sell limited Schedule V products without a prescription only if they are not prescription drugs, the buyer is 18 or older and identified, and a bound record is kept (21 CFR 1306.26).
Last updated: September 2026
10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales
Blueprint item 3.8 covers "requirements for the distribution and/or dispensing of non-prescription pharmaceutical products," including labeling, packaging and repackaging, and "dispensing-restricted, non-prescription drugs."
OTC labeling and packaging
Drug Facts label (21 CFR 201.66): OTC drugs carry a standardized panel listing the active ingredients (with the purpose of each), uses , warnings , directions , other information (such as storage), and inactive ingredients . A product lacking required labeling is misbranded .
Tamper-evident packaging (21 CFR 211.132): most OTC drugs must be in tamper-evident packaging, with a label statement describing the feature.
Child-resistant packaging: the PPPA covers listed OTC products above threshold amounts, such as aspirin, acetaminophen over 1 g per package, ibuprofen over 1 g, iron over 250 mg elemental, and diphenhydramine over 66 mg (Section 10.4).
Repackaging: changing an OTC product's container or labeling to further distribute it is "repackaging" under Utah law (§ 58-17b-102(66)) and brings manufacturer-type labeling duties. Dispensing an OTC drug on a practitioner's order is dispensing , and a § 58-17b-602 label applies (§ 58-17b-102(22)).
Store signs: a non-pharmacy business may display "packaged drugs," "drug sundries," or "nonprescription drugs" without being treated as a pharmacy (§ 58-17b-501(3)(b)).
Counseling: a technician may counsel on OTC drugs and dietary supplements under the supervising pharmacist's direction (R156-17b-601(1)(j)). Questions about prescription drugs go to a pharmacist or intern.
- Pseudoephedrine, ephedrine, and phenylpropanolamine
- Utah (§ 58-37c-208)
Quantity: a retail distributor or mobile retail vendor may not sell more than 3.6 grams in any 24-hour period, regardless of the number of transactions. A mobile retail vendor is also limited to 7.5 grams per 30 days .
Storage: products must be kept where customers can't reach them , or in a locked display case only employees can open. Non-liquid products must be in blister packs of no more than two dosage units per blister.
Identification: the buyer must show government-issued photo ID with date of birth .
Log: the buyer provides or writes name, address, date of birth , the date and time , and a signature . The seller verifies identity and records the brand name and quantity . Keep the log at least two years from the most recent entry.
Warning: the log or a prominent sign must include the federal false-statement warning (18 U.S.C. § 1001).
Confidentiality: log information may be released only to law enforcement enforcing controlled substance laws, or to the purchaser about their own purchases.
Possession: an unlicensed person who possesses more than 9 grams is guilty of a class A misdemeanor . Pharmacists, retailers, and others possessing it in the regular course of lawful business, and people with a valid prescription, have an affirmative defense (§ 58-37c-207). Online sales use an electronic tracking system (§ 58-37c-209).
Federal CMEA (21 CFR Part 1314)
Federal law adds a 9-gram limit per 30 days per purchaser (7.5 grams for mail-order or mobile sales), requires sellers to self-certify with DEA and train employees, and requires the logbook. Utah pharmacies comply with both sets of rules.
Iodine matrix above 1.5% (§ 58-37c-204)
Iodine at concentrations above 1.5% by weight , a methamphetamine precursor, may be sold only:
as a prescription drug on a prescription from a Utah-licensed veterinarian or physician . The prescription must state a specified number of refills , may be electronic, and may be filled by someone other than the prescriber; or
to a person engaged in livestock animal husbandry .
A retailer must store it so the public can't reach it without an employee's help, and keep a record (receipts are enough) of each buyer. Selling to an unqualified buyer is a class B misdemeanor. Crystal iodine sales by licensed regulated sellers require photo ID, a signed certificate, and a thumbprint (§ 58-37c-202).
Schedule V without a prescription (federal rule)
21 CFR 1306.26 allows a pharmacist to dispense a Schedule V product that is not a prescription drug under the FDCA without a prescription, but only if:
a pharmacist makes the sale (a non-pharmacist may complete the cash transaction after the pharmacist decides);
no more than 240 mL or 48 dosage units of an opium-containing product, or 120 mL or 24 dosage units of any other controlled substance, is sold to the same purchaser in 48 hours ;
- the purchaser is at least 18 and shows identification if not known to the pharmacist;
- a bound record book records the buyer's name and address, product, quantity, date, and pharmacist; and
other federal, state, or local law doesn't require a prescription.
Most codeine combinations are now prescription drugs, so this pathway is rarely used. In Utah, gabapentin (Schedule V) is a prescription drug and is always dispensed on a prescription. Utah's statute requires a written prescription whenever federal law requires one (§ 58-37-304(3)(a)).
Other restricted or behind-the-counter items
Naloxone 4 mg nasal spray has been approved for OTC sale since 2023. Prescription products and insurance billing still use the standing order or pharmacist prescribing (Section 7.1).
Levonorgestrel 1.5 mg emergency contraception is OTC with no age restriction . Ulipristal requires a prescription.
Human insulins (regular, NPH, 70/30) are federally non-prescription but are typically kept behind the counter so the pharmacist can counsel. Analog insulins require a prescription.
Tobacco and nicotine: OTC nicotine replacement is labeled for adults. Pharmacist prescribing of prescription cessation products is covered in Section 6.3.